Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
71.66 +0.88 (+1.24%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 71.66 unch (unch) 16:27 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
70.36
Day High
72.28
Open 70.85
Previous Close 70.78 70.78
Volume 2,857,900 2,857,900
Avg Vol 4,905,445 4,905,445
Stochastic %K 76.52% 76.52%
Weighted Alpha -18.53 -18.53
5-Day Change +3.09 (+4.51%) +3.09 (+4.51%)
52-Week Range 57.52 - 138.80 57.52 - 138.80
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,459,762
  • Shares Outstanding, K 392,107
  • Annual Sales, $ 4,033 M
  • Annual Income, $ 576,200 K
  • EBIT $ 600 M
  • EBITDA $ 818 M
  • 60-Month Beta 1.50
  • Price/Sales 6.97
  • Price/Cash Flow 31.88
  • Price/Book 13.31

Options Overview Details

View History
  • Implied Volatility 56.08% ( -3.05%)
  • Historical Volatility 53.82%
  • IV Percentile 83%
  • IV Rank 56.52%
  • IV High 78.36% on 10/09/24
  • IV Low 27.12% on 05/16/24
  • Put/Call Vol Ratio 0.20
  • Today's Volume 3,803
  • Volume Avg (30-Day) 5,285
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 123,828
  • Open Int (30-Day) 122,547

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.33
  • Number of Estimates 11
  • High Estimate 0.43
  • Low Estimate 0.28
  • Prior Year 0.32
  • Growth Rate Est. (year over year) +3.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.52 +24.58%
on 04/04/25
Period Open: 73.55
73.50 -2.50%
on 04/10/25
-1.89 (-2.57%)
since 03/25/25
3-Month
57.52 +24.58%
on 04/04/25
Period Open: 88.75
93.25 -23.15%
on 02/18/25
-17.09 (-19.26%)
since 01/24/25
52-Week
57.52 +24.58%
on 04/04/25
Period Open: 138.01
138.80 -48.37%
on 04/26/24
-66.35 (-48.08%)
since 04/25/24

Most Recent Stories

More News
2 Cash-Producing Stocks That Stand Out and 1 to Keep Off Your Radar

2 Cash-Producing Stocks That Stand Out and 1 to Keep Off Your Radar

EYE : 12.30 (+1.07%)
TTD : 53.97 (+1.31%)
DXCM : 71.66 (+1.24%)
3 New ETFs Finding Early Traction With Investors

Markets have tumbled in 2025, but three funds launched this year have the potential to outshine even longer-established ETFs.

MSFT : 391.85 (+1.17%)
TMUS : 232.77 (-11.22%)
TSEL : 23.13 (+1.43%)
DECK : 109.19 (-1.32%)
QIDX : 9.84 (-0.19%)
AXP : 264.81 (-0.94%)
RILA : 9.78 (+0.85%)
SPY : 550.64 (+0.72%)
WMB : 59.03 (-0.97%)
DXCM : 71.66 (+1.24%)
Tariffs, Trump, and Turmoil

In this podcast, Motley Fool analysts talk about economic uncertainty, airlines, building materials, and assorted spirits.

BLK : 907.69 (-0.94%)
NFLX : 1,101.53 (+0.42%)
NVDA : 111.01 (+4.30%)
IBKR : 169.28 (+0.14%)
JPM : 243.55 (-0.45%)
DAL : 41.58 (-1.05%)
RPM : 104.44 (-1.05%)
MELI : 2,225.85 (+0.95%)
WFC : 69.73 (+0.24%)
KMX : 65.03 (-0.99%)
AMC : 2.71 (unch)
STZ : 185.35 (-1.15%)
What to Expect From DexCom's Next Quarterly Earnings Report

DexCom will release its first-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

XLV : 138.05 (+0.48%)
$SPX : 5,525.21 (+0.74%)
DXCM : 71.66 (+1.24%)
Stocks Sink on Global Economic Angst

The S&P 500 Index ($SPX ) (SPY ) today is down -5.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -4.68%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -6.25%. June E-mini S&P futures...

GOOGL : 161.96 (+1.68%)
MPC : 137.44 (-0.07%)
AAPL : 209.28 (+0.44%)
ADI : 194.59 (-0.33%)
LVS : 35.89 (-1.97%)
SLB : 34.52 (-1.17%)
WYNN : 82.11 (+0.65%)
OXY : 40.36 (-0.02%)
TSLA : 284.95 (+9.80%)
FANG : 136.76 (+0.44%)
AMD : 96.64 (+2.30%)
SPY : 550.64 (+0.72%)
Stocks Retreat on Continued Global Economic Uncertainty

The S&P 500 Index ($SPX ) (SPY ) today is down -2.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -2.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.75%. June E-mini S&P futures...

GOOGL : 161.96 (+1.68%)
AAPL : 209.28 (+0.44%)
ADI : 194.59 (-0.33%)
LVS : 35.89 (-1.97%)
WYNN : 82.11 (+0.65%)
OXY : 40.36 (-0.02%)
TSLA : 284.95 (+9.80%)
FANG : 136.76 (+0.44%)
AMD : 96.64 (+2.30%)
SPY : 550.64 (+0.72%)
META : 547.27 (+2.65%)
MU : 79.78 (+3.05%)
2 Growth Stocks to Buy in the Tariff-Fueled Market Correction

What should investors do during a market downturn? Some might resort to panic selling, but that's hardly a good strategy. Unless a company's investment thesis has changed because of recent developments,...

GOOG : 163.85 (+1.47%)
GOOGL : 161.96 (+1.68%)
DXCM : 71.66 (+1.24%)
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

RMD : 235.88 (-0.09%)
MASI : 163.74 (+0.68%)
PODD : 260.71 (+0.51%)
IRTC : 105.99 (+1.15%)
DXCM : 71.66 (+1.24%)
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

RMD : 235.88 (-0.09%)
MASI : 163.74 (+0.68%)
IRTC : 105.99 (+1.15%)
PODD : 260.71 (+0.51%)
DXCM : 71.66 (+1.24%)
DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes

DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose...

ABT : 128.85 (-0.41%)
NVO : 62.08 (-0.88%)
PODD : 260.71 (+0.51%)
DXCM : 71.66 (+1.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 74.43
2nd Resistance Point 73.36
1st Resistance Point 72.51
Last Price 71.66
1st Support Level 70.58
2nd Support Level 69.51
3rd Support Level 68.66

See More

52-Week High 138.80
Fibonacci 61.8% 107.75
Fibonacci 50% 98.16
Fibonacci 38.2% 88.57
Last Price 71.66
52-Week Low 57.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective